SEOUL -- SD Biosensor rose sharply in its stock market debut on Friday as the South Korean coronavirus test kit maker benefited from a strong business performance and individual investor fever over initial public offerings in the country.
Shares in the Suwon-based company closed up 7.0% at 61,000 won, after starting trading 9.6% higher than the initial public offering price of 52,000 won. Its market cap reached 6.3 trillion won ($5.5 billion), landing it in 59th place among companies listed on the benchmark Kospi index.
